HPPCn activates signaling pathways involved in the survival of HCC cells and up-regulates myeloid cell leukemia-1 (Mcl-1) expression via the MAPK and SPK1 pathways (Chang et al., 2010; Liu et al., 2013). This evidence concerns the gene ANP32A and hepatocellular carcinoma.